GlassScriptPhysician profile
Andrew J Edwards
NPI 1710066097
$3,375.68
in general payments reported to CMS, 2019-2025
24 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $223 · 2021: $1,157 · 2022: $697 · 2023: $381 · 2024: $343 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.02 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $544.24 | 2019-2023 | Ubrelvy |
| Sumitomo Pharma America, INC. | $436.94 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $395.24 | 2021-2022 | |
| Astellas Pharma US INC | $348.92 | 2019-2025 | Veozah, Myrbetriq |
| Bausch Health US, LLC | $289.10 | 2019-2023 | Wellbutrin, Aplenzin |
| Mayne Pharma Commercial LLC | $186.17 | 2021-2025 | |
| Therapeuticsmd, INC. | $178.02 | 2019-2021 | |
| Evofem Biosciences, INC. | $164.97 | 2020-2023 | Phexxi |
| Virtus Pharmaceuticals LLC | $121.31 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $112.79 | 2019-2020 | |
| Hologic Sales and Service, LLC | $103.01 | 2020-2024 | Aptima |
| Exeltis, USA INC. | $101.70 | 2021-2022 | |
| Shield Therapeutics INC | $68.32 | 2022 | |
| Scynexis, INC. | $53.39 | 2022 | |
| Avion Pharmaceuticals | $40.79 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $40.13 | 2019-2022 | |
| Millicent US INC | $35.83 | 2019-2025 | Intrarosa |
| Agile Therapeutics, INC. | $31.10 | 2021 | |
| Allergan, INC. | $28.91 | 2019-2020 | |
| Minerva Surgical, INC | $22.12 | 2019-2021 | |
| Azurity Pharmaceuticals, INC. | $21.32 | 2023 | Adthyza |
| Lupin INC. | $17.48 | 2019 | |
| Coopersurgical, INC. | $17.12 | 2021 | |
| Mylan Pharmaceuticals INC. | $16.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.